Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2026 Update
Nuvation Bio Inc NUVB
$4.66
▲ +3.33%
(+$0.15)
Open
$4.38
Prev Close
$4.51
Day Range
$4.35 – $4.67
52W Range
$1.57 – $9.75
Market Cap
$1.57B
Beta
1.55
EPS (TTM)
$-0.43
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2020-07-01 |
| Shares Out. | 348,200,000 |
| Website | nuvationbio.com/ ↗ |
| Phone | 13322086102 |
Nuvation Bio Inc is a publicly traded company under the ticker symbol NUVB on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-05-01)
📰 Latest News for NUVB
Nuvation Bio to collaborate with Thermo Fisher Scientific for U.S.-based manufacturing of Ibtrozi for ROS1-positive non-small cell lung cancer
Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment
Shares of lifesciences and medical equipment stocks are trading higher following strong earnings from Sartorius.
Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc. (NUVB) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Nuvation Bio Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08
Nuvation Bio Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates